...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Name Confusion
6
Jul 17, 2020 01:31PM
2
Jul 22, 2020 12:06PM
3
Jul 22, 2020 12:14PM
3
Jul 22, 2020 01:59PM
1
Jul 22, 2020 03:14PM
1
Jul 25, 2020 12:13PM
2
Jul 25, 2020 04:34PM
2
Jul 25, 2020 04:39PM
1
Jul 26, 2020 09:29PM
4
Jul 29, 2020 08:59AM
3
Jul 29, 2020 10:58AM
3
Jul 29, 2020 11:24AM
3
Jul 29, 2020 11:36AM
4
Jul 29, 2020 11:43AM
5
Jul 29, 2020 11:57AM
3
Jul 29, 2020 12:37PM
6
Jul 29, 2020 01:00PM
4
Jul 29, 2020 01:21PM
2
Jul 29, 2020 03:20PM
3
Aug 12, 2020 08:47AM
6
Aug 12, 2020 12:16PM

& this just back from IR:

"Hello .........Zenith has updated their FAQ section on the website to address the OTC Markets issue to the best they can at this time, with emphasis that this was/is completely out of Zenith’s control (please refer to question #4) https://www.zenithepigenetics.com/about/FAQ

Best regards,

ZEN IR"

so it looks like a person is on their own to get this fixed....

3
Aug 12, 2020 03:04PM
Share
New Message
Please login to post a reply